Elicio Therapeutics Inc.
$ 3.19
1.59%
07 Aug - close price
- Market Cap 83,784,000 USD
- Current Price $ 3.19
- High / Low $ 3.27 / 3.13
- Stock P/E N/A
- Book Value -0.08
- EPS -2.37
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.92 %
- ROE -10.76 %
- 52 Week High 16.00
- 52 Week Low 2.66
About
Elicio Therapeutics Inc. (ELTX) is a clinical-stage biotechnology company specializing in innovative immunotherapies for cancer treatment. Its lead product candidate, Eli-002, leverages a proprietary Amphiphilic TLR9 Agonist to elicit robust immune responses against various cancer types, aiming to enhance patient outcomes. By concentrating on personalized cancer vaccines and groundbreaking immunotherapeutic approaches, Elicio Therapeutics is uniquely positioned to tackle significant unmet clinical needs in oncology, while advancing its compelling pipeline through rigorous clinical trials that could redefine the standard of cancer care.
Analyst Target Price
$20.00
Quarterly Earnings
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-08-06 | 2026-05-11 | 2026-03-12 | 2025-11-13 | 2025-08-07 | 2025-05-13 | 2025-03-31 | 2024-11-13 | 2024-08-13 | 2024-05-15 | 2024-02-13 | 2023-11-09 |
| Reported EPS | -0.66 | -0.65 | -0.49 | -0.6 | -0.66 | -0.87 | -1.02 | -1.39 | -0.64 | -1.15 | -1.75 | -1.27 |
| Estimated EPS | -0.53 | -0.46 | -0.445 | -0.48 | -0.69 | -0.83 | -0.875 | -0.73 | -0.96 | -1.09 | -0.78 | -0.8 |
| Surprise | -0.13 | -0.19 | -0.045 | -0.12 | 0.03 | -0.04 | -0.145 | -0.66 | 0.32 | -0.06 | -0.97 | -0.47 |
| Surprise Percentage | -24.5283% | -41.3043% | -10.1124% | -25% | 4.3478% | -4.8193% | -16.5714% | -90.411% | 33.3333% | -5.5046% | -124.359% | -58.75% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: ELTX
2026-08-06 00:01:54
Certain common stock of Elicio Therapeutics, Inc. are under a lock-up agreement set to expire on August 6, 2026. The lock-up period for these shares started on July 6, 2026, and lasts for 31 days. This agreement restricts officers and directors from selling or disposing of their common stock for the specified duration.
2026-08-06 00:01:54
Elicio Therapeutics, Inc. has certain warrants under a lock-up agreement that ends on August 6, 2026. The lock-up period for these warrants began on July 6, 2026, and lasts for 31 days. This agreement restricts officers and directors from selling or disposing of common stock or convertible securities during this period, with some exceptions.
2026-07-29 04:40:34
The article reports on Elicio Therapeutics Inc.'s (ELTX) institutional confidence score, which stands at 3.00, placing it 192nd out of 385 in the Biotechnology & Medical Research industry. The institutional shareholding proportion increased by 37.43% quarter-over-quarter, reaching 15.12%. James Simons is noted as the largest institutional shareholder, holding 0.66% of outstanding shares.
2026-07-28 22:09:36
This article provides a detailed cash flow statement for Elicio Therapeutics Inc (ELTX), including quarterly and annual data for operating, investing, and financing activities. It presents financial figures such as net income, capital expenditures, and changes in working capital across multiple fiscal years. The article also includes a FAQ section defining different types of cash flow and their significance for investors.
2026-07-28 22:09:36
This article provides financial information for Elicio Therapeutics, Inc (HAM:9HA), specifically focusing on its price to sales ratio. The content lists the company's trading information on the Hamburg Stock Exchange and indicates that no trades have occurred for the period. It also details the various data sources used for financial and reference information.
2026-07-28 12:10:53
This article provides working capital per share data for Elicio Therapeutics, Inc (HAM:9HA) on the Hamburg Stock Exchange. The market was closed at the time of publication, with no trades recorded. The content is presented as part of TradingView's financial data offerings.
